Atria Wealth Solutions’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-32,643
Closed -$7.94M 1750
2022
Q2
$7.94M Buy
+32,643
New +$8M 0.15% 146

Other funds holding AMGN

Atria Wealth Solutions's AMGN Position: Q2 2025 in Review

Atria Wealth Solutions reduced its Amgen (AMGN) stake by 71% in Q2 2025, selling an estimated $7.83M and leaving 11,385 shares worth $3.21M. The position accounts for 0.07% of the portfolio, ranked #298.

Atria Wealth Solutions first reported a position in AMGN in Q1 2022 and has held it in 14 quarters since. The position peaked at $14.3M in Q3 2024. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Atria Wealth Solutions held 11,385 shares of Amgen worth $3.21M as of Q2 2025.
  • Atria Wealth Solutions sold 27,644 Amgen shares in Q2 2025, an estimated $7.83M.
  • Amgen made up 0.07% of Atria Wealth Solutions's portfolio in Q2 2025, its #298 holding.
  • Atria Wealth Solutions first reported a position in Amgen in Q1 2022 and has held it in 14 quarters since.
  • Atria Wealth Solutions's Amgen position peaked at $14.3M in Q3 2024.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.